Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Bayoglu, Ibrahim; Yildiz, İBRAHİM; Varol, Umut; Cokmert, Suna; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Akyol, Murat; Demir, Lutfiye; Dirican, Ahmet; Tarhan, Oktay

doi:10.5114/wo.2015.53374

Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Bayoglu I. V., Yildiz İ., Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., ...Daha Fazla

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.19, sa.5, ss.385-390, 2015 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 5
Basım Tarihi: 2015
Doi Numarası: 10.5114/wo.2015.53374
Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.385-390
Anahtar Kelimeler: uracil/tegafur, metastatic colorectal cancer, heavily pretreated, salvage therapy
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.